TREA

98326058 - FERTIN PHARMA

Follow

Information

  • Trademark
  • 98326058
  • Serial Number
    98326058
  • Filing Date
    December 21, 2023
    2 years ago
  • Transaction Date
    March 03, 2025
    a year ago
  • Status Date
    January 13, 2025
    a year ago
  • Published for Opposition Date
    October 15, 2024
    a year ago
  • Location Date
    November 26, 2024
    a year ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BHANOT, KAPIL
  • Attorney Docket Number
    PMPS 2313858
    Attorney Name
    Tamar Niv Bessinger
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
3
Mark Identification
FERTIN PHARMA
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals and nutraceuticals; consultancy regarding the custom manufacture of pharmaceuticals and nutraceuticals; custom manufacture of pharmaceuticals, namely, formulation of pharmaceutical preparations for treatment of a wide variety of conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; custom manufacture of pharmaceuticals, namely, formulation of inhaled therapeutics; custom manufacture of pharmaceuticals, namely, formulation of pharmaceuticals and well-being products for oral and intra-oral delivery systems; research, and development of pharmaceuticals and well-being products for oral and intra-oral delivery systems; custom manufacture of pharmaceuticals, namely, formulation of pharmaceuticals for smoking cessation; provision of advice, information and consultancy in relation to the aforesaid services
  • DM0000: The mark consists of The stylized wording "FERTIN PHARMA" with an outline of an oblong oval encompasses the letters "F" and "E" in the word "FERTIN", and the letter "P" in "PHARMA", italicized, is placed directly under the letter "R" in "FERTIN".
  • GS0051: Pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; aerosolized and inhaled therapeutics and pharmaceuticals, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti- pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; drug delivery agents in the form of fast liquefiable tablets, compressed gum, extruded gum, lozenges, pouch powder, dissolvable films, coatings for tablets, and transdermal patches that facilitate the delivery of pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; dietetic foodstuffs adapted for medical purposes; nicotine gum for use as an aid to stop smoking; medicated chewing gum as a drug delivery agent to facilitate the delivery of pharmaceutical preparations; dietetic preparations for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes
  • CC0000: Color is not claimed as a feature of the mark.
  • DS0000: "PHARMA"
  • GS0421: Scientific, medical and technological services and research and design relating thereto namely, research and development of technology in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; industrial analysis and industrial research services in the field of pharmaceutical research and development services; research, and development of pharmaceutical preparations for treatment of a wide variety of conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; research and development of inhaled therapeutics; research, and development of pharmaceuticals and well-being products for oral and intra-oral delivery systems; research and development of pharmaceuticals for smoking cessation; provision of advice, information and consultancy in relation to the aforesaid service
Case File Event Statements
  • 12/21/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/2/2024 - 2 years ago
    4 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 4/2/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/3/2024 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 5/23/2024 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/24/2024 - a year ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/24/2024 - a year ago
    8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/24/2024 - a year ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/21/2024 - a year ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/21/2024 - a year ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/21/2024 - a year ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/4/2024 - a year ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/4/2024 - a year ago
    12 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 9/5/2024 - a year ago
    14 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 10/15/2024 - a year ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/26/2024 - a year ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/25/2024 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/15/2024 - a year ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/13/2025 - a year ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/14/2025 - a year ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/4/2025 - a year ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/13/2025 - a year ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT